129 related articles for article (PubMed ID: 38422396)
1. Ongoing Measles in the Developed and Developing World.
Cherry JD
J Pediatric Infect Dis Soc; 2024 Apr; 13(4):233-236. PubMed ID: 38422396
[TBL] [Abstract][Full Text] [Related]
2. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
Pallivathucal LB; Noymer A
Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
[TBL] [Abstract][Full Text] [Related]
3. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
[TBL] [Abstract][Full Text] [Related]
4. The upsurge of SSPE--a reflection of national measles immunization status in Pakistan.
Ibrahim SH; Amjad N; Saleem AF; Chand P; Rafique A; Humayun KN
J Trop Pediatr; 2014 Dec; 60(6):449-53. PubMed ID: 25232151
[TBL] [Abstract][Full Text] [Related]
5. Subacute sclerosing panencephalitis should be eliminated by measles vaccination.
Liu WL; He ZX; Li F; He D; Ai R
Hum Vaccin Immunother; 2017 Sep; 13(9):2038-2040. PubMed ID: 28750182
[TBL] [Abstract][Full Text] [Related]
6. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
Zilber N; Rannon L; Alter M; Kahana E
Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
[TBL] [Abstract][Full Text] [Related]
7. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B
J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482
[TBL] [Abstract][Full Text] [Related]
8. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
Wendorf KA; Winter K; Zipprich J; Schechter R; Hacker JK; Preas C; Cherry JD; Glaser C; Harriman K
Clin Infect Dis; 2017 Jul; 65(2):226-232. PubMed ID: 28387784
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
Modlin JF; Jabbour JT; Witte JJ; Halsey NA
Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological aspects of SSPE].
Nihei K
Nihon Rinsho; 2007 Aug; 65(8):1460-5. PubMed ID: 17695284
[TBL] [Abstract][Full Text] [Related]
11. Health impact of measles vaccination in the United States.
Bloch AB; Orenstein WA; Stetler HC; Wassilak SG; Amler RW; Bart KJ; Kirby CD; Hinman AR
Pediatrics; 1985 Oct; 76(4):524-32. PubMed ID: 3931045
[TBL] [Abstract][Full Text] [Related]
12. Risk factors in subacute sclerosing panencephalitis: a case-control study.
Halsey NA; Modlin JF; Jabbour JT; Dubey L; Eddins DL; Ludwig DD
Am J Epidemiol; 1980 Apr; 111(4):415-24. PubMed ID: 7377184
[TBL] [Abstract][Full Text] [Related]
13. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
[TBL] [Abstract][Full Text] [Related]
14. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
Bojinova V; Dimova P; Belopitova L; Mihailov A; Gatcheva N; Mihneva Z; Todorova M
Neuroepidemiology; 2004; 23(5):254-7. PubMed ID: 15316253
[TBL] [Abstract][Full Text] [Related]
15. Subacute Sclerosing Panencephalitis: The Foothold in Undervaccination.
Holt RL; Kann D; Rassbach CE; Schwenk HT; Ritter JM; Rota PA; Elbers J
J Pediatr; 2016 Dec; 179():259-262. PubMed ID: 27634625
[TBL] [Abstract][Full Text] [Related]
16. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
Enders-Ruckle G
Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
[TBL] [Abstract][Full Text] [Related]
17. Review of the effect of measles vaccination on the epidemiology of SSPE.
Campbell H; Andrews N; Brown KE; Miller E
Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
[TBL] [Abstract][Full Text] [Related]
18. Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.
Manning L; Laman M; Edoni H; Mueller I; Karunajeewa HA; Smith D; Hwaiwhanje I; Siba PM; Davis TM
PLoS Negl Trop Dis; 2011 Jan; 5(1):e932. PubMed ID: 21245918
[TBL] [Abstract][Full Text] [Related]
19. [Prospects of measles and subacute sclerosing panencephalitis (SSPE) elimination in Poland].
Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska-Buksowicz B; Kulczycki J
Neurol Neurochir Pol; 1999; 33(3):653-63. PubMed ID: 10540725
[TBL] [Abstract][Full Text] [Related]
20. Subacute sclerosing panencephalitis: clinical and demographic characteristics.
Rafique A; Amjad N; Chand P; Zaidi SS; Rana MS; Ahmed K; Ibrahim S
J Coll Physicians Surg Pak; 2014 Aug; 24(8):557-60. PubMed ID: 25149833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
